Lee's Pharmaceutical Holdings Limited (0950.HK)
HKD 1.36
(2.26%)
HKD 1.36
(2.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 113.82 Million | 283.63 Million | 210.68 Million | 218.91 Million | 399.95 Million | 321.25 Million |
| Net Income | 16.69 Million | 67.86 Million | 1.96 Billion | 134.03 Million | 122.88 Million | 446.38 Million |
| Depreciation & Amortization | 149.5 Million | 152.49 Million | 146.86 Million | 127.5 Million | 94.14 Million | 68.1 Million |
| Deferred income taxes | -345.14 Million | - | -1.98 Billion | 14.89 Million | 159.37 Million | -250.32 Million |
| Stock-based compensation | 793 Thousand | 12.1 Million | 16.88 Million | 17.44 Million | 5.46 Million | 15.7 Million |
| Change in working capital | -76.12 Million | -15 Million | 64.51 Million | -71.28 Million | 45.54 Million | 47.04 Million |
| Other non-cash items | 22.95 Million | 66.17 Million | -1.5 Million | -3.68 Million | -27.45 Million | -5.66 Million |
| Investing Cash Flow | -146.75 Million | -256.05 Million | -370.28 Million | -523.74 Million | -261.41 Million | -489.95 Million |
| Investments in PPE | -159.71 Million | -213.82 Million | -370.72 Million | -358.13 Million | -360.57 Million | -305.84 Million |
| Acquisitions | 99 Thousand | 880 Thousand | -3.63 Million | -165.55 Million | -2.4 Million | 80.46 Million |
| Investment purchases | -6.7 Million | -45.5 Million | -28.37 Million | -20.25 Million | -32.34 Million | -204.94 Million |
| Sales/Maturities of investments | - | -880 Thousand | -327.41 Million | 45.04 Million | 123.6 Million | 5.93 Million |
| Other Investing Activities | 19.56 Million | 3.27 Million | 359.86 Million | -24.84 Million | 10.3 Million | -65.57 Million |
| Financing Cash Flow | 13.43 Million | -128.59 Million | 60.97 Million | -9.8 Million | 323.79 Million | -25.13 Million |
| Debt repayment | -35.33 Million | -151.88 Million | -122.61 Million | -160.42 Million | -53.67 Million | -71.33 Million |
| Dividends payments | -10.59 Million | -24.14 Million | -35.91 Million | -38.22 Million | -60.41 Million | -61.56 Million |
| Common Stock Repurchased | - | - | - | 157.18 Million | -19.67 Million | - |
| Common Stock Issuance | - | - | 3.54 Million | 446 Thousand | 1.39 Million | 5.37 Million |
| Other Financing Activities | 182 Thousand | 47.42 Million | 215.96 Million | 31.22 Million | 456.16 Million | 102.38 Million |
| Accounts receivables | 43.43 Million | 92.35 Million | -12.58 Million | -27.38 Million | -7.84 Million | -75.57 Million |
| Accounts payables | -26.82 Million | 39.48 Million | -11.34 Million | -6.51 Million | 14.1 Million | 40.13 Million |
| Inventory | -61.96 Million | 43.27 Million | 43.34 Million | -147.46 Million | -53.23 Million | -66.76 Million |
| Other working capital | -30.77 Million | -190.11 Million | 45.1 Million | 110.08 Million | 92.52 Million | 113.81 Million |
| Cash at beginning of period | 189.3 Million | 277.52 Million | 375.19 Million | 693.51 Million | 222.29 Million | 396.14 Million |
| Cash at end of period | 173.19 Million | 189.3 Million | 277.52 Million | 375.19 Million | 693.51 Million | 222.29 Million |
| Capital Expenditure | -159.71 Million | -213.82 Million | -370.72 Million | -358.13 Million | -360.57 Million | -305.84 Million |
| Effect of forex changes on cash | -76 Thousand | 12.78 Million | 955 Thousand | -3.68 Million | 8.88 Million | 19.99 Million |
| Net cash flow / Change in cash | -16.1 Million | -88.22 Million | -97.67 Million | -318.31 Million | 471.22 Million | -173.84 Million |
| Free Cash Flow | -45.89 Million | 69.8 Million | -160.04 Million | -139.22 Million | 39.37 Million | 15.4 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 16.69 Million | 290.5 Thousand | 290.5 Thousand | 8.05 Million | 8.05 Million | 67.86 Million |
| Depreciation & Amortization | 149.5 Million | 15.1 Million | 15.1 Million | 38.87 Million | 38.87 Million | 152.49 Million |
| Deferred income taxes | -345.14 Million | -117.85 Million | - | - | - | - |
| Stock-based compensation | 793 Thousand | 99 Thousand | 99 Thousand | 297.5 Thousand | 297.5 Thousand | 12.1 Million |
| Change in working capital | -76.12 Million | -25.75 Million | -25.75 Million | - | - | -15 Million |
| Other non-cash items | 22.95 Million | 45.76 Million | 45.76 Million | -27.69 Million | -27.69 Million | 66.17 Million |
| Investing Cash Flow | -146.75 Million | -28.31 Million | -28.31 Million | -44.29 Million | -44.29 Million | -256.05 Million |
| Investments in PPE | -159.71 Million | -7.42 Million | -7.42 Million | -7.29 Million | -7.29 Million | -213.82 Million |
| Acquisitions | 99 Thousand | -7500.00 | -7500.00 | - | - | 880 Thousand |
| Investment purchases | -6.7 Million | -6.7 Million | - | - | - | -45.5 Million |
| Sales/Maturities of investments | - | 1.00 | - | - | - | -880 Thousand |
| Other Investing Activities | 19.56 Million | -20.88 Million | -20.88 Million | -37 Million | -37 Million | 3.27 Million |
| Financing Cash Flow | 13.43 Million | -3.65 Million | -3.65 Million | 10.37 Million | 10.37 Million | -128.59 Million |
| Debt repayment | -35.33 Million | - | - | - | - | -151.88 Million |
| Dividends payments | -10.59 Million | -2.35 Million | -2.35 Million | -2.94 Million | -2.94 Million | -24.14 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 182 Thousand | -1.29 Million | -1.29 Million | 13.31 Million | 13.31 Million | 47.42 Million |
| Accounts receivables | 43.43 Million | 10.54 Million | 10.54 Million | - | - | 92.35 Million |
| Accounts payables | -26.82 Million | - | - | - | - | 39.48 Million |
| Inventory | -61.96 Million | -30.98 Million | -30.98 Million | - | - | 43.27 Million |
| Other working capital | -30.77 Million | -5.31 Million | -5.31 Million | - | - | -190.11 Million |
| Cash at beginning of period | 189.3 Million | 161.51 Million | - | 189.3 Million | - | 277.52 Million |
| Cash at end of period | 173.19 Million | 173.19 Million | 3 Million | 161.51 Million | -13.89 Million | 189.3 Million |
| Capital Expenditure | -159.71 Million | -7.42 Million | -7.42 Million | -7.29 Million | -7.29 Million | -213.82 Million |
| Effect of forex changes on cash | -76 Thousand | -538 Thousand | -538 Thousand | 500 Thousand | 500 Thousand | 12.78 Million |
| Net cash flow / Change in cash | -16.1 Million | 11.67 Million | 3 Million | -27.78 Million | -13.89 Million | -88.22 Million |
| Free Cash Flow | -45.89 Million | 28.08 Million | 28.08 Million | 12.23 Million | 12.23 Million | 69.8 Million |
SAPR3
3705
PLUS
THRM
PEMSF
5269